trial · primary record
Opevesostat
Prostatic Neoplasms, Castration-Resistant
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 220 |
| Primary completion | 2029-01-15 |
| Primary endpoint | Number of participants who experience one or more dose-limiting toxicities (DLTs) |
| Registry ID | NCT06353386 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:35.952Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06353386
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.